OVID initiated with an Overweight rating at Cantor
TradeXchange Newsdesk reports that OVID was initiated with an Overweight rating by Cantor.
Story updates
10:42:57 AM UTC
SquawkNews
Ovid Therapeutics Initiated at Overweight by Cantor Fitzgerald